Search research articles
Contact Us
Filters
Showing results (421-430 of 437) with videos related to
Page
of 44
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
June 9, 2012
Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor
Daniel W Kung, Steven B Coffey, Ryan M Jones, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate
Samit K Bhattacharya, Kim Andrews, Ramsay Beveridge, et al.
ACS Medicinal Chemistry Letters
|
June 17, 2026
Structure-Guided Discovery of Selective Polo-Like Kinase 3 Inhibitors
Jeremy L Yap, Gabrielle Lovett, Jeremy W Mason, et al.
Molecular Psychiatry
|
August 2, 2012
Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model
J W Steele, M L Lachenmayer, S Ju, et al.
Journal of Medicinal Chemistry
|
September 10, 2020
Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose
Kentaro Futatsugi, Aaron C Smith, Meihua Tu, et al.
Blood
|
October 16, 2025
Impact of Modernizing Eligibility Criteria on Enrollment and Representation in Acute Myeloid Leukemia Clinical Trials
Andrew Hantel, Yating Wang, Angel Cronin, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 20, 2013
Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptor
Kim F McClure, Margaret Jackson, Kimberly O Cameron, et al.
Journal of Medicinal Chemistry
|
November 2, 2022
Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis
Kentaro Futatsugi, Shawn Cabral, Daniel W Kung, et al.
Journal of Medicinal Chemistry
|
December 23, 2022
Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4
Allyn T Londregan, Karlygash Aitmakhanova, James Bennett, et al.
Blood Advances
|
February 11, 2026
ASH 2026 Guidelines for Frontline Management of Acute Lymphoblastic Leukemia in Adolescents and Young Adults
Adam S DuVall, Jennifer McNeer, Matthew C Cheung, et al.
Page
of 44
Search research articles
Search
Showing results (421-430 of 437) with videos related to
Sort By:
Page
of 44
Bioorganic & Medicinal Chemistry Letters
|
June 9, 2012
Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor
Daniel W Kung, Steven B Coffey, Ryan M Jones, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate
Samit K Bhattacharya, Kim Andrews, Ramsay Beveridge, et al.
ACS Medicinal Chemistry Letters
|
June 17, 2026
Structure-Guided Discovery of Selective Polo-Like Kinase 3 Inhibitors
Jeremy L Yap, Gabrielle Lovett, Jeremy W Mason, et al.
Molecular Psychiatry
|
August 2, 2012
Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model
J W Steele, M L Lachenmayer, S Ju, et al.
Journal of Medicinal Chemistry
|
September 10, 2020
Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose
Kentaro Futatsugi, Aaron C Smith, Meihua Tu, et al.
Blood
|
October 16, 2025
Impact of Modernizing Eligibility Criteria on Enrollment and Representation in Acute Myeloid Leukemia Clinical Trials
Andrew Hantel, Yating Wang, Angel Cronin, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 20, 2013
Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptor
Kim F McClure, Margaret Jackson, Kimberly O Cameron, et al.
Journal of Medicinal Chemistry
|
November 2, 2022
Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis
Kentaro Futatsugi, Shawn Cabral, Daniel W Kung, et al.
Journal of Medicinal Chemistry
|
December 23, 2022
Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4
Allyn T Londregan, Karlygash Aitmakhanova, James Bennett, et al.
Blood Advances
|
February 11, 2026
ASH 2026 Guidelines for Frontline Management of Acute Lymphoblastic Leukemia in Adolescents and Young Adults
Adam S DuVall, Jennifer McNeer, Matthew C Cheung, et al.
Page
of 44